Abstract B098: Unbiased in vitro and in vivo drug anchor screens identify mechanisms of resistance and sensitization for MTA-cooperative PRMT5 inhibitors in MTAP-deleted cancer models
Steven Lombardo(Io Therapeutics (United States)), Teng Teng(Beijing Wuzi University), John P. Maxwell(Tango Therapeutics (United States)), Tenzing Khendu(Tango Therapeutics (United States)), Jannik N. Andersen(Tango Therapeutics (United States)), Alan Huang(Tango Therapeutics (United States)), Yi Yu(Novartis (United States)), Shangtao Liu(Tango Therapeutics (United States)), Ashley H Choi(Io Therapeutics (United States)), Silvia Fenoglio(Tango Therapeutics (United States)), Binzhang Shen(Tango Therapeutics (United States)), Lauren Grove(Tango Therapeutics (United States)), Samuel R. Meier, Hannah Stowe(Massachusetts General Hospital), Kimberly J. Briggs(Io Therapeutics (United States)), James M. Tepper(Rutgers, The State University of New Jersey), Matthew R. Tonini(Tango Therapeutics (United States)), Kevin M. Cottrell(Io Therapeutics (United States))
Cited by 0